TAKIFFANY PALMER: Open Payments
NPI 1215418975 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 33 payments from 13 companies in 2025. Trend: 2023 $562 · 2024 $531 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $114 |
| ABBVIE INC. | 7 | $114 |
| Aimmune Therapeutics, Inc. | 5 | $95 |
| Ardelyx, Inc. | 4 | $70 |
| Janssen Biotech, Inc. | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Celltrion USA Inc. | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
Products named: DUPIXENT, ZENPEP, IBSRELA, SKYRIZI, RINVOQ, TREMFYA, XIFAXAN, VEGZELMA.
Industry payments across MS — which companies pay providers there.
